Symposium 23：Interstitial Lung Disease
The etiology of ILD is quite diverse, which adds a lot of difficulty to the diagnosis. At the same time, although there are breakthroughs in the current treatment, there is still no way to reverse the disease process for the patients. Therefore, understanding the disease, early diagnosis and early treatment can truly benefit the patients. This symposium, we will introduce the latest developments in the current treatment strategy of ILD. We also introduce the consensus of hypersensitive pneumonitis and progressive pulmonary fibrosis which were written by TPSCCM
Date: Sunday, April 28, 2023 | Time: 15:00-16:30 (GMT+8)
| Time (GMT+8) |
Topic | Speaker | Country / Region |
|---|---|---|---|
| 15:00-15:30 | The new treatment strategy of IPF | Dr. Toru Arai | Japan |
| 15:30-16:00 | The hypersensitive pneumonitis consensus in Japan | Prof. Yoshikazu Inoue | Japan |
| 16:00-16:30 | The progressive pulmonary fibrosis consensus of Taiwan | TBD | TBD |
